
ERK regulation of phosphodiesterase 4 enhances dopamine
Sep 17, 2013 · We developed a dynamical model to study the effects of phosphodiesterase 4 (PDE4), a cAMP phosphodiesterase that is phosphorylated and inhibited by ERK, on the membrane insertion of AMPAR. The model predicted that PKA could be a downstream effector of ERK in regulating AMPAR insertion.
ERK regulation of phosphodiesterase 4 enhances dopamine …
We developed a dynamical model to study the effects of phosphodiesterase 4 (PDE4), a cAMP phosphodiesterase that is phosphorylated and inhibited by ERK, on the membrane insertion of AMPAR. The model predicted that PKA could be a downstream effector of ERK in regulating AMPAR insertion.
The role of ERK2 docking and phosphorylation of PDE4 cAMP ...
ERK2 (extracellular-signal-regulated kinase 2) interacts with the PDE4 catalytic unit by binding to a KIM (kinase interaction motif) docking site located on an exposed beta-hairpin loop and an FQF (Phe-Gln-Phe) specificity site located on an exposed alpha-helix.
PDE4 cAMP phosphodiesterases: modular enzymes that …
PDE4 isoforms are 'designed' to be regulated by extracellular-signal-related protein kinase (ERK), which binds to anchor sites on the PDE4 catalytic domain that it phosphorylates.
PDE4 Phosphodiesterases in Cardiovascular Diseases: Key ...
This review summarizes the current knowledge and recent advances in understanding the contribution of the PDE4 subfamily to cardiovascular function and underscores the intricate challenges associated with targeting PDE4 enzymes as a therapeutic strategy for the management of cardiovascular diseases. Keywords: PDE4, cardiovascular diseases ...
Inhibition of the Phosphodiesterase 4 (PDE4) Enzyme Reverses
Apr 28, 2004 · These results suggest that MEK/ERK signaling plays an inhibitory role in regulating PDE4 activity in the brain; this may be a novel mechanism by which MEK/ERK signaling mediates memory.
Remodelling of the PDE4 cAMP phosphodiesterase isoform profile …
May 5, 2004 · Monocytes and macrophages provide key targets for the action of novel anti-inflammatory therapeutics targeted at inhibition of PDE4 cAMP-specific phosphodiesterases. PDE4 enzymes provide the dominant cAMP phosphodiesterase activity …
ERK regulation of phosphodiesterase 4 enhances dopamine ... - PNAS
Aug 28, 2013 · We developed a dynamical model to study the effects of phosphodiesterase 4 (PDE4), a cAMP phosphodiesterase that is phosphorylated and inhibited by ERK, on the membrane insertion of AMPAR. The model predicted that PKA could be a downstream effector of ERK in regulating AMPAR insertion.
Phosphodiesterase-4 enzyme as a therapeutic target in …
Oct 1, 2020 · Inhibition of PDE4 enzymes by epidermal growth factor (EGF) via ERK activation increases cAMP levels [76]. Crosstalk between cAMP and ERK signalling in hippocampal cornu ammonis-1 (CA1) region is shown to be involved in synaptic plasticity [77, 78].
Targeting phosphodiesterase 4 as a therapeutic strategy for …
Jan 1, 2023 · This review describes its structure and PDE4 mediated signaling pathways, summarizes the role of individual subtypes and recent progress in PDE4 inhibitors for cognitive improvement, trying to offer an outlook of targeting PDE4 for cognitive enhancement in future.